Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ALGXYOTCMKTS:DGENOTCMKTS:DNAGOTCMKTS:VRACY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALGXYAffinity Energy and Health$0.00$0.00▼$0.26N/A135.11800 shsN/ADGENDeltagen$0.00$0.00▼$0.00N/AN/AN/AN/ADNAGDNAPrint Genomics$0.00$0.00▼$0.00N/A-0.47N/AN/AVRACYViralytics$3.75$0.00$1.50▼$4.10N/AN/A247 shsN/AMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALGXYAffinity Energy and Health0.00%0.00%0.00%0.00%0.00%DGENDeltagen0.00%0.00%0.00%0.00%0.00%DNAGDNAPrint Genomics0.00%0.00%0.00%0.00%0.00%VRACYViralytics0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALGXYAffinity Energy and HealthN/AN/AN/AN/AN/AN/AN/AN/ADGENDeltagenN/AN/AN/AN/AN/AN/AN/AN/ADNAGDNAPrint GenomicsN/AN/AN/AN/AN/AN/AN/AN/AVRACYViralyticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALGXYAffinity Energy and Health 0.00N/AN/AN/ADGENDeltagen 0.00N/AN/AN/ADNAGDNAPrint Genomics 0.00N/AN/AN/AVRACYViralytics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALGXYAffinity Energy and Health$2.05MN/AN/AN/AN/AN/ADGENDeltagenN/AN/AN/AN/AN/AN/ADNAGDNAPrint GenomicsN/AN/AN/AN/AN/AN/AVRACYViralyticsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALGXYAffinity Energy and Health-$6.08MN/A0.00N/AN/AN/AN/AN/AN/ADGENDeltagenN/AN/A0.00N/AN/AN/AN/AN/AN/ADNAGDNAPrint GenomicsN/AN/A0.00N/AN/AN/AN/AN/AN/AVRACYViralyticsN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALGXYAffinity Energy and HealthN/AN/AN/AN/AN/ADGENDeltagenN/AN/AN/AN/AN/ADNAGDNAPrint GenomicsN/AN/AN/AN/AN/AVRACYViralyticsN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALGXYAffinity Energy and HealthN/ADGENDeltagenN/ADNAGDNAPrint GenomicsN/AVRACYViralyticsN/AInsider OwnershipCompanyInsider OwnershipALGXYAffinity Energy and HealthN/ADGENDeltagen46.00%DNAGDNAPrint GenomicsN/AVRACYViralyticsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALGXYAffinity Energy and HealthN/AN/AN/ANot OptionableDGENDeltagen150N/AN/ANot OptionableDNAGDNAPrint Genomics24N/AN/ANot OptionableVRACYViralyticsN/AN/AN/ANot OptionableVRACY, ALGXY, DGEN, and DNAG HeadlinesRecent News About These CompaniesOncolytics: the dawn of a new era in cancer treatmentOctober 17, 2024 | pharmaphorum.comPViralytics lifted by FDA panel verdict on T-VecSeptember 6, 2024 | pharmaphorum.comPBig pharma could turn to viruses to boost cancer immunotherapiesAugust 16, 2024 | pharmaphorum.comPReflection and refraction of light - CCEAMay 27, 2024 | bbc.co.ukBridgewater founder Ray Dalio warns of danger of US debt to Treasury marketMay 18, 2024 | ft.comViewRay, Inc. (VRAY)April 22, 2024 | finance.yahoo.com50% Off Ray-Ban Promo Codes - MarchMarch 20, 2024 | latimes.comWhat is Billy Ray Cyrus' net worth?March 6, 2024 | celebritynetworth.comCThe best 4K Blu-ray players 2024: Ultra HD marvels chosen by our expertsMarch 3, 2024 | techradar.comTThe Ray D'Arcy ShowFebruary 13, 2024 | rte.ieRDistrict Attorney Once Linked To Jerry Sandusky Investigation Disappears: "It’s Truly Like He Did Vanish Into Thin Air"February 5, 2024 | oxygen.comORay, MI Weather ConditionsFebruary 1, 2024 | wunderground.comWTo Inhibit or Not to Inhibit MEK With BRAF Inhibitors: Is That the Question?January 5, 2024 | ascopubs.orgARay Romano Explains Why an ‘Everybody Loves Raymond’ Reboot Is ‘Out of the Question'December 20, 2023 | mensjournal.comMoncolytic virusDecember 15, 2023 | pharmaphorum.comPRachael Ray Cookware ReviewsDecember 14, 2023 | consumeraffairs.comCRay Anderson out at Arizona State? Good luck to whoever's nextNovember 25, 2023 | azcentral.comALenses and ray diagrams - OCR GatewayNovember 25, 2023 | bbc.co.ukArizona State Athletic Director Ray Anderson resignsNovember 24, 2023 | azcentral.comATop broker names 3 healthcare shares to buyOctober 27, 2023 | fool.com.auMedia Sentiment Over TimeVRACY, ALGXY, DGEN, and DNAG Company DescriptionsAffinity Energy and Health OTCMKTS:ALGXYAffinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.Deltagen OTCMKTS:DGENDeltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.DNAPrint Genomics OTCMKTS:DNAGDNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.Viralytics OTCMKTS:VRACYViralytics Limited, a biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies in Australia and internationally. The company's lead investigational product is CAVATAK, a proprietary formulation of an oncolytic common cold virus that is in Phase Ib clinical trials for the treatment of melanoma, and lung and bladder cancer; Phase II clinical trials for the treatment of late stage melanoma; and in pre-clinical studies for the treatment of prostate and breast cancer, multiple myeloma, pancreatic cancer, malignant glioma, acute myeloid leukemia, and chronic lymphocytic leukemia. It is also developing EVATAK to treat ovarian, prostate, and gastric cancer. The company was formerly known as Psiron Ltd. and changed its name to Viralytics Limited in December 2006. Viralytics Limited is headquartered in Sydney, Australia. As of June 20, 2018, Viralytics Limited operates as a subsidiary of Merck Sharp & Dohme (Holdings) Pty Ltd. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
